< Back to latest news & events

Event

UPC event in Ireland: Maintaining commercial relevance of your European IP strategy with the new Unified Patent Court system

August 2022

Event date: 6th October 2022

Join HGF in association with Ibec for our networking event and panel discussion exploring the practical ramifications of the Unitary Patent and Unified Patent Court

Date

Thursday 6th October, 2022

Time

6PM

Venue

The Guinness Enterprise Centre (GEC), Dublin

About the event

The patent landscape in Europe is on the brink of the most significant change in a generation; a change that could significantly alter what is the most commercially relevant and cost-effective patent strategy for your business. We invite you to learn more about the strategic considerations and practicalities of the Unitary Patent (UP) and Unified Patent Court (UPC).

Our panellists will discuss:

  • What does this mean for Irish businesses of all sizes and across all sectors for existing European patents and for future IP strategies?
  • What are the advantages and cost benefits of the UP and UPC for Irish businesses; and
  • What steps does Ireland need to take to be able to access the benefits the UPC could bring?
Panellists
  • Naoise Gaffney, Head of Intellectual Property, GH Research and Chair of the Ibec Corporate IP Group
  • Fiona Ryan, Start Up & Entrepreneurship Lecturer, Technological University Dublin and Co-Founder of Colata
  • Joe Doyle, Intellectual Property Manager, Enterprise Ireland
  • Andrew Knox, Lecturer in Biochemistry and Principal Investigator, Technological University Dublin and Founder of MyWorkaway
  • Rachel Fetches, Partner & Head of Law, HGF
  • Marie Walsh, Patent Director, HGF
Ireland and UPC

All Irish businesses will need to make important decisions now about their European patents as the UPC will affect all granted European patents and pending European patent applications, irrespective of the status of the Irish government’s progress towards ratification of the UPC Agreement. Additionally, the European Patent office (EPO) has announced new measures for supporting users in an early uptake of the UP.

Looking forward, there is a significant opportunity for Ireland to enhance its reputation as a hub for end-to-end IP activity, including obtaining and enforcement of IP rights. An Irish Local Division of the Unified Patent Court would support the further expansion of the patent-intensive sectors across the country, creating jobs, benefitting all Irish businesses and boosting Ireland’s innovation performance.

Further, the European UPC’s Central Division must find a new location, instead of London, for the cases it will handle in the chemicals, biopharmaceuticals and medical device sectors. These industries are key contributors to the Irish economy. As an English-speaking, common law jurisdiction, with strong links to the US and the rest of the world, Ireland is well-placed as a location for the Central Division Court which would mean easier access to enforcement of IP rights for Irish-based companies in those sectors.

Latest updates

Managing IP Rising Stars 2024

We are delighted to announce that 12 of our esteemed attorneys have been listed in the 2024 Managing Intellectual Property (MIP) Rising Stars guide! This prestigious recognition highlights the best …

Read article
Event - 15th - 16th October 2024

LSPN North America Fall 2024

HGF are proud to be platinum sponsors of LSPN North America Fall 2024. This year’s event will be held in San Francisco on Tuesday 15th and Wednesday 16th of October …

Event details

Agritech Thymes: Exploring the Agritech IP landscape – past trends and future insights

The agrifood patent landscape analysis recently reported by WIPO provides interesting insights into key areas of innovation and the IP strategies being adopted. The agrifood industry, encompassing both agritech and …

Read article

The Patent Lawyer: UPC’s first year: emergence of a purely civil law system?

The UPC passed its milestone 1 year anniversary on 1 June 2024. At the time of writing we are still awaiting the first substantive decisions on invalidity and infringement, there …

Read article

NK Cell Therapy – an IP update

Advances in CAR-T cell therapy have carved a path for improved treatments in the field of oncology, in particular haematological cancers. In 2018, the European Medicine’s Agency approved the first …

Read article

IP Ingredients: Can you patent a flavour?

If you’ve developed a new drink or food with a distinct flavour or mouthfeel and aren’t sure if it’s patentable, then this article may be for you. We explore broadly …

Read article